Back

The Effect of Short Message Service (SMS)-Reminders on Child Health in Parents of Newborns: A Pilot Randomised Controlled Trial

Shah, M.; Ramsay, J. A.; Dymock, M.; Marsh, J.; Newall, N.; McCallum, C.; Davis, J.; Snelling, T.

2021-01-13 allergy and immunology
10.1101/2021.01.12.21249639 medRxiv
Show abstract

BackgroundIncomplete vaccination in Australia is greatly due to vaccine hesitancy, which is driven by multiple factors. Studies analysing the effect of behavioural nudges on vaccine uptake have shown promising results. Although there is some evidence for positively framed SMS vaccine messages, evidence is lacking for loss-based framed messages which may be highly effective but may paradoxically risk increasing vaccine hesitancy. This pilot study aimed to evaluate the effect of loss-based framed SMS messages on vaccine hesitancy. MethodsThis single-blinded randomised controlled trial enrolled pregnant women from antenatal clinics in King Edward Memorial Hospital, Perth, WA which delivers approximately 6000 higher-risk infants per year. Participants were randomised to receive either a loss-based framed SMS message warning of the risks of failure to vaccinate, or a sham SMS message unrelated to vaccination, and were asked to complete the short-scale vaccine hesitancy questionnaire before and after the intervention. DiscussionThe application of behavioural sciences through SMS-reminders has the potential to improve vaccination rates. There are difficulties in engaging with parents of newborns about vaccine hesitancy. Further research is warranted using other approaches to recruitment. HighlightsO_LIPilot randomised controlled trial on the use of SMS reminders to influence vaccine hesitancy C_LIO_LIApplication of behavioural economics, nudge techniques and mobile health C_LIO_LIVaccine hesitancy measured using the short-scale PACV questionnaire C_LIO_LIThere are difficulties in engaging with parents of newborns about vaccine hesitancy C_LIO_LIFurther research needed to optimise message framing, timing and reduce vaccine hesitancy C_LI Trial RegistrationThe trial is registered with the Australia and New Zealand Clinical Trials Register (ACTRN12618001510235).

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.